| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Yevgeny Savransky | |
| Mayank Patel | |||
| Daniela Levi | |||
| Elliot R. Goodman | |||
| P2860 | cites work | Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults | Q22250906 |
| Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein | Q24310224 | ||
| Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus | Q24535547 | ||
| NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel | Q28248503 | ||
| Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance | Q29012156 | ||
| Role of spirometric and arterial gas data in predicting pulmonary complications after abdominal surgery | Q31863693 | ||
| The role of leptin in human obesity and disease: a review of current evidence | Q33601309 | ||
| Prevention of multiple organ failure | Q33811370 | ||
| Prophylaxis for deep venous thrombosis and pulmonary embolism in the surgical patient | Q33912478 | ||
| Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up | Q33912526 | ||
| Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics | Q33937527 | ||
| Airway management and direct laryngoscopy. A review and update | Q34002352 | ||
| Effects of obesity on pharmacokinetics implications for drug therapy | Q34053786 | ||
| The mini-gastric bypass: experience with the first 1,274 cases | Q34082708 | ||
| Laparoscopy: searching for the proper insufflation gas. | Q34104657 | ||
| Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion | Q34106543 | ||
| Management of the obese critically ill patient | Q34162361 | ||
| Obesity and the metabolic response to severe multiple trauma in man | Q34177522 | ||
| Care of the obesity surgery patient requiring immediate-level care or intensive care. | Q34256136 | ||
| The flexible bronchoscope. A tool for anesthesiologists | Q34302908 | ||
| Gastric bypass | Q34393629 | ||
| Laparoscopic surgery for morbid obesity | Q34393668 | ||
| Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients. | Q34473300 | ||
| Monitoring for suspected pulmonary embolism. | Q34485192 | ||
| Gallbladder management in obesity surgery | Q34613618 | ||
| Gastric bypass in obesity | Q34706873 | ||
| Gastric bypass for treating severe obesity | Q36748600 | ||
| Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes | Q38304787 | ||
| Effect of weight loss on the ECG of normotensive morbidly obese patients | Q38494471 | ||
| Utility of illness severity scoring for prediction of prolonged surgical critical care | Q39420869 | ||
| Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues | Q39642183 | ||
| Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature | Q41270670 | ||
| The obese patient in the ICU. | Q41719726 | ||
| Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients | Q42166279 | ||
| Morphine-induced venodilation in humans | Q42552229 | ||
| The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism | Q42581797 | ||
| The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. | Q42603791 | ||
| Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity | Q42634370 | ||
| The utility of contrast studies and drains in the management of patients after Roux-en-Y gastric bypass | Q42670995 | ||
| Leptin and HDL-cholesterol in non-diabetic normotensive subjects | Q43659169 | ||
| Intravenous insulin nomogram improves blood glucose control in the critically ill. | Q43730568 | ||
| Metabolic syndrome in severely obese patients | Q43761737 | ||
| Glucose disposal in morbidly obese patients in the early post-operative period | Q43844757 | ||
| Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes | Q43844761 | ||
| The Laryngeal Mask Airway ProSeal(TM) as a temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation | Q43898044 | ||
| Systemic inflammatory response after laparoscopic and open application of adjustable banding for morbidly obese patients | Q43970503 | ||
| High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity | Q44881377 | ||
| Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease | Q44882541 | ||
| Long-term effects of gastric surgery for treating respiratory insufficiency of obesity | Q44927506 | ||
| The cardiomyopathy of obesity | Q45215029 | ||
| Morbid obesity and tracheal intubation | Q46075781 | ||
| The effect of body weight on dalteparin pharmacokinetics. A preliminary study | Q47231213 | ||
| Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients | Q47569947 | ||
| Cardiovascular function in extreme obesity | Q47987737 | ||
| Morbid obesity in the medical ICU. | Q48676735 | ||
| Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia | Q48727889 | ||
| Gastric surgery for respiratory insufficiency of obesity | Q49010051 | ||
| The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. | Q50867766 | ||
| The effects of the reverse trendelenburg position on respiratory mechanics and blood gases in morbidly obese patients during bariatric surgery. | Q51372031 | ||
| Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. | Q51434538 | ||
| Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study. | Q51444479 | ||
| Remifentanil pharmacokinetics in obese versus lean patients. | Q51501421 | ||
| Efficacy of hypocaloric total parenteral nutrition in hospitalized obese patients: a prospective, double-blind randomized trial. | Q51595523 | ||
| The Australian Incident Monitoring Study. Difficult intubation: an analysis of 2000 incident reports. | Q51653801 | ||
| Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. | Q53489244 | ||
| Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. | Q54154576 | ||
| Obesity in the new millennium | Q59070727 | ||
| Optimizing Results of Gastric Bypass | Q67320561 | ||
| A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters | Q68159794 | ||
| Leaks occurring after gastric bariatric operations | Q68263094 | ||
| APACHE II score does not predict multiple organ failure or mortality in postoperative surgical patients | Q68746613 | ||
| Surgery for morbid obesity. Using an inflatable gastric band | Q68795092 | ||
| Subclavian vein catheterizations: a prospective study. I. Non-infectious complications | Q70548946 | ||
| Postoperative chest percussion with postural drainage in obese patients following gastric stapling | Q70671156 | ||
| Obesity and cardiac function | Q70868135 | ||
| Biliopancreatic diversion for obesity at eighteen years | Q71052717 | ||
| Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity | Q71550568 | ||
| Prevention of venous thromboembolism | Q71732662 | ||
| Cardiovascular effects of obesity and hypertension | Q72526521 | ||
| Some complications after laparoscopic nonadjustable gastric banding | Q73291498 | ||
| Role of radiologic contrast studies in the early postoperative period after bariatric surgery | Q73362798 | ||
| Current practices in the prophylaxis of venous thromboembolism in bariatric surgery | Q73545045 | ||
| Fluconazole serum concentrations and pharmacokinetics in an obese patient | Q73766906 | ||
| Gastric banding: intraoperative and early postoperative complications and their prevention | Q73885063 | ||
| Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity | Q74606288 | ||
| Leptin as an acute phase reactant after non-adjustable laparoscopic gastric banding | Q74606316 | ||
| Prevention of venous thromboembolism | Q77579049 | ||
| Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery | Q77700350 | ||
| The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62L) | Q78006715 | ||
| Special pharmacokinetics of fluconazole in septic, obese and burn patients | Q89704478 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| digestive system surgery | Q5275614 | ||
| P304 | page(s) | 11-32 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Critical Care Clinics | Q15757467 |
| P1476 | title | Critical care of the obese and bariatric surgical patient | |
| P478 | volume | 19 |
| Q38694963 | A Multimodal Analgesic Protocol Reduces Opioid-Related Adverse Events and Improves Patient Outcomes in Laparoscopic Sleeve Gastrectomy |
| Q48273867 | A comparison between the Boussignac™ continuous positive airway pressure mask and the venturi mask in terms of improvement in the PaO2/F(I)O2 ratio in morbidly obese patients undergoing bariatric surgery: a randomized controlled trial |
| Q61775722 | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIA |
| Q38177743 | Analgesic treatment in laparoscopic gastric bypass surgery: a systematic review of randomized trials. |
| Q48577001 | Anesthetic management of laparoscopic adjustable gastric banding in Japanese patients with morbid obesity |
| Q39406059 | Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy |
| Q48585868 | Boussignac CPAP in the postoperative period in morbidly obese patients |
| Q36331619 | Clinical and critical care concerns in severely ill obese patient |
| Q35675079 | Clinical approach to the critically ill, morbidly obese patient |
| Q40826790 | Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery? |
| Q36206711 | Gastrointestinal complications of bariatric surgery |
| Q36017753 | Obesity and lower limb venous disease - The epidemic of phlebesity |
| Q42670504 | Obesity increases mortality in liver transplantation--the Danish experience |
| Q37924442 | Pharmaconutrition for the obese, critically ill patient |
| Q98210358 | Spinal anesthesia for cesarean section in a super morbidly obese parturient: A case report |
| Q36585945 | The consequences of obesity on trauma, emergency surgery, and surgical critical care |
| Q36550740 | Use of positive pressure in the bariatric surgery and effects on pulmonary function and prevalence of atelectasis: randomized and blinded clinical trial. |
Search more.